Concerns Regarding Injections: When injecting BPC-157 or TB-500, there is a risk of injection site reactions such as pain, redness, or swelling
Additional information Details Original published date: Media and public enquiries Media Enquiries: Health Canada 613-957-2983 [email protected] Public Enquiries: 613-957-2991 1-866-225-0709 [email protected] Get notified Receive emails about new and updated recall and safety alerts.
Side Effects & Safety BPC-157 has an excellent safety profile in available research: Minimal Adverse Effects Local injection site reaction: mild, transient Nausea: rare (mild when present) Headache: rare, typically with high doses No systemic toxicity reported at therapeutic doses Why It's Safe It's a naturally occurring peptide your body makes Exogenously administered doses are small (micrograms) No off-target receptor effects documented No organ toxicity in animal studies at 100x therapeutic doses Important caveat : BPC-157 is not FDA-approved
These are the cells power plants, providing them with energy
Another study demonstrated that supplementing with omega-3s for 32 weeks led to a dramatic improvement in sperm concentration
Prevalence of sarcopenia and its association with diabetes: a meta-analysis of community-dwelling Asian population
